Interestingly, besides an increased CRC burden, we observed inflammation-associated symptoms as well as epithelial damage in the colon upon the conditional, intestine-specific deletion of Usp22 in Apc-mutated mice [13]. Here, USP22 is linked to colorectal carcinoma.